We share your mission to develop life-changing cell therapies that holds immense potential for transforming healthcare to patients around the world. Since the cells themselves are the drug product, meeting safety and efficacy standards requires achieving high yield of your target cell and phenotype.
Cell therapy is rapidly evolving and gathering speed, presenting patients with new therapeutic options. There is an imperative need to accelerate progress, from discovery, to process development, to clinical and commercialization with end-to-end solutions to meet demands for pace and scale.
This half-day workshop leverage decades of industry experience to help you navigate these challenges, ensuring performance and scalability with a simplified path to regulatory approvals.
Associate Principal I Pharma & Lifescience Consulting
IQVIA, Thailand
General Manager
Tofflon Group Engineering Business Department, China
Director CMC & R&D
Hilleman Laboratories, Singapore
Technical Application Manager
Tofflon Group, Singapore
General Manager of South East AsiaÂ
Tofflon Group, Singapore
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.